CBLL CeriBell, Inc.
Healthcare$18.80+0.16%ClosedMarket Cap: $713.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.02
P/S
7.49
EV/EBITDA
-11.63
DCF Value
$-41.83
FCF Yield
-7.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.7%
Operating Margin
-68.3%
Net Margin
-63.5%
ROE
-38.2%
ROA
-33.9%
ROIC
-39.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $26.5M | 87.3% | $-20.7M | $-19.7M | $— | — |
| Q4 null | $24.8M | 87.3% | $-14.6M | $-13.5M | $— | — |
| FY null | $89.1M | 87.9% | $-58.4M | $-53.4M | $— | — |
| Q3 null | $22.6M | 88.3% | $-14.6M | $-13.5M | $— | — |
| Q2 null | $21.2M | 88.1% | $-15.0M | $-13.6M | $— | — |
| Q1 null | $20.5M | 87.9% | $-14.2M | $-12.8M | $— | — |
| Q4 null | $18.5M | 87.6% | $-12.9M | $-12.6M | $— | — |
| FY null | $65.4M | 86.7% | $-39.7M | $-40.5M | $— | — |
| Q3 null | $17.2M | 87.3% | $-9.9M | $-10.4M | $— | — |
| Q2 null | $14.9M | 85.8% | $-8.4M | $-8.7M | $— | — |
| Q1 null | $14.9M | 85.8% | $-8.4M | $-8.7M | $— | — |
| Q4 2023 | $13.1M | 84.7% | $-8.4M | $-8.3M | $1.74 | — |